ADVANCED HEALTH LIMITED - Strategic Review of Advanced Health
Strategic Review of Advanced Health
ADVANCED HEALTH LIMITED
(Incorporated in the Republic of South Africa)
(Registration number 2013/059246/06)
(“the Company” or “AVL”)
ISIN Code: ZAE000189049 JSE Code: AVL
STRATEGIC REVIEW OF ADVANCED HEALTH
Shareholders are referred to the announcement released by AVL on 15 June 2022 and are advised that the
strategic review of the Advanced Health group is ongoing. AVL confirms that it has received inbound
approaches from several parties interested in a potential acquisition of its shares within PresMed Australia,
the Australian subsidiary of AVL.
The appointed AVL sub-committee is now further evaluating these approaches, with the assistance of its
Australian advisors, Monash Advisory. There are no assurances that the AVL board will decide to pursue, nor
that any transaction or transactions will materialise. Shareholders do not need to take any action in relation
to this. AVL will continue to keep shareholders informed about the progress and outcomes of the current
evaluation process.
Pretoria
25 August 2022
Designated Advisor
Grindrod Bank Limited
Date: 25-08-2022 03:30:00
Produced by the JSE SENS Department. The SENS service is an information dissemination service administered by the JSE Limited ('JSE').
The JSE does not, whether expressly, tacitly or implicitly, represent, warrant or in any way guarantee the truth, accuracy or completeness of
the information published on SENS. The JSE, their officers, employees and agents accept no liability for (or in respect of) any direct,
indirect, incidental or consequential loss or damage of any kind or nature, howsoever arising, from the use of SENS or the use of, or reliance on,
information disseminated through SENS.
Profile Group (Pty) Ltd. has taken care in preparing all information on this website, but does not accept any liability for errors or out-of-date information.
